Jerome Cluzeau, Ph.D. - Publications

Affiliations: 
2004 Université de Montréal, Montréal, Canada 
Area:
Organic Chemistry

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Smilovic IG, Cluzeau J, Richter F, Nerdinger S, Schreiner E, Laus G, Schottenberger H. Synthesis of enantiopure antiobesity drug lorcaserin. Bioorganic & Medicinal Chemistry. PMID 29496415 DOI: 10.1016/J.Bmc.2018.02.038  0.368
2017 Cluzeau J, Stavber G. Development and optimization of a new synthetic process for lorcaserin. Bioorganic & Medicinal Chemistry. PMID 29254893 DOI: 10.1016/J.Bmc.2017.12.009  0.342
2011 Troiani V, Cluzeau J, Časar Z. Application of chemoselective pancreatin powder-catalyzed deacetylation reaction in the synthesis of key statin side chain intermediate (4 R,6 S)-4-(tert-butyldimethylsilyloxy)-6-(hydroxymethyl)tetrahydropyran-2-one Organic Process Research and Development. 15: 622-630. DOI: 10.1021/op100341m  0.314
2008 Suzuki Y, Cluzeau J, Hara T, Hirasawa A, Tsujimoto G, Oishi S, Ohno H, Fujii N. Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines. Archiv Der Pharmazie. 341: 554-61. PMID 18763715 DOI: 10.1002/Ardp.200700269  0.368
2007 Tomita K, Oishi S, Cluzeau J, Ohno H, Navenot JM, Wang ZX, Peiper SC, Akamatsu M, Fujii N. SAR and QSAR studies on the N-terminally acylated pentapeptide agonists for GPR54. Journal of Medicinal Chemistry. 50: 3222-8. PMID 17579384 DOI: 10.1021/Jm070064L  0.428
2007 Cluzeau J, Oishi S, Ohno H, Wang Z, Evans B, Peiper SC, Fujii N. Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists. Organic & Biomolecular Chemistry. 5: 1915-23. PMID 17551641 DOI: 10.1039/B702649H  0.443
2007 Boeglin D, Hamdan FF, Melendez RE, Cluzeau J, Laperriere A, Héroux M, Bouvier M, Lubell WD. Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor. Journal of Medicinal Chemistry. 50: 1401-8. PMID 17319653 DOI: 10.1021/Jm061343W  0.594
2007 Ueda S, Oishi S, Wang ZX, Araki T, Tamamura H, Cluzeau J, Ohno H, Kusano S, Nakashima H, Trent JO, Peiper SC, Fujii N. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities. Journal of Medicinal Chemistry. 50: 192-8. PMID 17228861 DOI: 10.1021/Jm0607350  0.534
2006 Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, Wang ZX, Peiper SC, Fujii N. Structure-activity relationship study on small peptidic GPR54 agonists. Bioorganic & Medicinal Chemistry. 14: 7595-603. PMID 16879969 DOI: 10.1016/J.Bmc.2006.07.009  0.38
2005 Cluzeau J, Lubell WD. Design, synthesis, and application of azabicyclo[X.Y.0]alkanone amino acids as constrained dipeptide surrogates and peptide mimics. Biopolymers. 80: 98-150. PMID 15795926 DOI: 10.1002/Bip.20213  0.544
2004 Van Cauwenberghe S, Simonin F, Cluzeau J, Becker JA, Lubell WD, Tourwé D. Structure-activity study of the ORL1 antagonist Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH2. Journal of Medicinal Chemistry. 47: 1864-7. PMID 15027881 DOI: 10.1021/Jm031034V  0.5
2004 Cluzeau J, Lubell WD. Conformationally constrained dipeptide surrogates with aromatic side-chains: synthesis of 4-aryl indolizidin-9-one amino acids by conjugate addition to a common alpha,omega-diaminoazelate enone intermediate. The Journal of Organic Chemistry. 69: 1504-12. PMID 14987004 DOI: 10.1021/Jo0355855  0.563
2001 Cluzeau J, Lubell WD. Remarkable asymmetric induction from remote stereocenters in conjugate addition chemistry for the synthesis of alkyl-branched α, ω-diaminoazelates Israel Journal of Chemistry. 41: 271-282. DOI: 10.1560/E1Uk-Etwj-Wlmf-Nha2  0.539
2001 Demange L, Cluzeau J, Ménez A, Dugave C. Synthesis of optically pure N-Boc-protected (2R,3R)- and (2R,3S)-3-fluoroprolines Tetrahedron Letters. 42: 651-653. DOI: 10.1016/S0040-4039(00)02030-X  0.352
Show low-probability matches.